Press Release Details - Smiths Group plc

Cookies

The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >

19 January 2017

Smiths Group welcomes European Commission clearance for acquisition of Morpho Detection

Smiths Group plc (“Smiths Group”) welcomes the European Commission’s clearance of the proposed acquisition of Morpho Detection.

In order to secure approval in Phase I of the EU merger review process, Smiths Group proposed the divestment of Morpho Detection’s explosive trace detection (“Trace”) business. This divestment is conditional on the successful closing of Smiths Group’s acquisition of Morpho Detection and on the European Commission's approval of the purchaser of the Trace business as a suitable purchaser.

Completion of the acquisition of Morpho Detection by Smiths Group remains conditional upon approval from the relevant authorities in the United States and certain other territories, among other conditions. Smiths Group continues to engage with these authorities in order to secure the necessary clearances as soon as possible.







back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy